We provide you with 20 years of free, institutional-grade data for EXEL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EXEL. Explore the full financial landscape of EXEL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$22,910,685
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Eckhardt Sue Gail | Sale | -9,812 | $50.14 | $491,974 | 2026-06-03 |
| WYSZOMIERSKI JACK L | Sale | -3,925 | $50.55 | $198,409 | 2026-06-03 |
| Heyman Tomas J. | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Eckhardt Sue Gail | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Smith Julie | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Freire Maria C | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Beckerle Mary C | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Oliver Bob | Grant, award...etc | 8,367 | 2026-05-29 | ||
| WYSZOMIERSKI JACK L | Grant, award...etc | 8,367 | 2026-05-29 | ||
| POSTE GEORGE | Grant, award...etc | 8,367 | 2026-05-29 | ||
| PAPADOPOULOS STELIOS | Grant, award...etc | 8,367 | 2026-05-29 | ||
| Aftab Dana | Sale | -43,451 | $50.35 | $2,187,758 | 2026-05-28 |
| Haley Patrick J. | Sale | -32,110 | $49.81 | $1,599,399 | 2026-05-22 |
| MORRISSEY MICHAEL | Sale | -128,497 | $51.1 | $6,566,197 | 2026-05-19 |
| Senner Christopher J. | Sale | -75,793 | $51.1 | $3,873,022 | 2026-05-19 |
| Haley Patrick J. | Sale | -33,265 | $51.1 | $1,699,842 | 2026-05-19 |
| Hefti Brenda | Sale | -13,036 | $51.1 | $666,140 | 2026-05-19 |
| Aftab Dana | Sale | -30,578 | $51.1 | $1,562,536 | 2026-05-19 |
| Freire Maria C | Sale | -20,634 | $46 | $949,164 | 2026-05-08 |
| Freire Maria C | Derivatives Exercise | 20,634 | 2026-05-08 | ||
| POSTE GEORGE | Sale | -60,000 | $45.71 | $2,742,600 | 2026-05-08 |
| Beckerle Mary C | Sale | -7,712 | $48.45 | $373,646 | 2026-05-08 |
| Beckerle Mary C | Derivatives Exercise | 3,856 | 2026-05-08 | ||
| Senner Christopher J. | Grant, award...etc | 52,018 | 2026-03-02 | ||
| Hefti Brenda | Grant, award...etc | 23,119 | 2026-03-02 | ||
| Haley Patrick J. | Grant, award...etc | 40,459 | 2026-03-02 | ||
| MORRISSEY MICHAEL | Grant, award...etc | 160,437 | 2026-03-02 | ||
| Aftab Dana | Grant, award...etc | 52,018 | 2026-03-02 | ||
| Aftab Dana | Sale | -47,918 | $44.5 | $2,132,351 | 2026-02-26 |
| Aftab Dana | Sale | -29,873 | $44.35 | $1,324,868 | 2026-02-23 |
| WYSZOMIERSKI JACK L | Sale | -99,574 | $44.01 | $4,382,252 | 2026-02-20 |
| WYSZOMIERSKI JACK L | Derivatives Exercise | 20,634 | 2026-02-20 | ||
| Smith Julie | Sale | -106,539 | $43.33 | $4,616,335 | 2026-02-19 |
| Smith Julie | Derivatives Exercise | 106,539 | 2026-02-19 | ||
| Senner Christopher J. | Sale | -100,765 | $43 | $4,332,895 | 2026-02-18 |
| Haley Patrick J. | Sale | -99,297 | $43.92 | $4,361,124 | 2026-02-18 |
| MORRISSEY MICHAEL | Sale | -489,996 | $43.92 | $21,520,624 | 2026-02-18 |
| MORRISSEY MICHAEL | Derivatives Exercise | 494,700 | 2026-02-18 | ||
| Eckhardt Sue Gail | Sale | -3,856 | $43.79 | $168,854 | 2026-02-18 |
| Aftab Dana | Sale | -39,205 | $43.92 | $1,721,884 | 2026-02-18 |
| Oliver Bob | Sale | -30,250 | $43.61 | $1,319,203 | 2026-02-18 |
| Oliver Bob | Derivatives Exercise | 9,088 | 2026-02-18 | ||
| Hefti Brenda | Sale | -24,099 | $43.92 | $1,058,428 | 2026-02-18 |
| Hefti Brenda | Grant, award...etc | 30,170 | 2025-12-05 | ||
| JOHNSON DAVID EDWARD | Open Market Purchase | 27,532 | $43.12 | 2025-11-26 | |
| Haley Patrick J. | Sale | -10,648 | $41.77 | $444,767 | 2025-11-24 |
| Haley Patrick J. | Sale | -23,539 | $41.93 | $986,990 | 2025-11-24 |
| Haley Patrick J. | Sale | -38,043 | $42.11 | $1,601,991 | 2025-11-24 |
| Hefti Brenda | Initial | 2025-11-20 | |||
| Aftab Dana | Sale | -48,383 | $42.5 | $2,056,278 | 2025-11-13 |
| Beckerle Mary C | Sale | -24,622 | $42.03 | $1,034,863 | 2025-11-13 |
| Beckerle Mary C | Derivatives Exercise | 5,784 | 2025-11-13 | ||
| PAPADOPOULOS STELIOS | Sale | -100,000 | $43.55 | $4,355,000 | 2025-11-13 |
| Aftab Dana | Grant, award...etc | 50,673 | 2025-10-10 | ||
| WYSZOMIERSKI JACK L | Sale | -7,535 | $43.09 | $324,683 | 2025-06-04 |
| Eckhardt Sue Gail | Sale | -18,838 | $42.74 | $805,136 | 2025-06-04 |
| Heyman Tomas J. | Grant, award...etc | 9,812 | 2025-05-30 | ||
| POSTE GEORGE | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Oliver Bob | Grant, award...etc | 9,812 | 2025-05-30 | ||
| WYSZOMIERSKI JACK L | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Freire Maria C | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Eckhardt Sue Gail | Grant, award...etc | 9,812 | 2025-05-30 | ||
| PAPADOPOULOS STELIOS | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Smith Julie | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Beckerle Mary C | Grant, award...etc | 9,812 | 2025-05-30 | ||
| Haley Patrick J. | Sale | -34,387 | $44.06 | $1,515,091 | 2025-05-22 |
| Heyman Tomas J. | Sale | -4,544 | $44.29 | $201,254 | 2025-05-22 |
| Hessekiel Jeffrey | Sale | -59,035 | $44.65 | $2,635,913 | 2025-05-16 |
| MORRISSEY MICHAEL | Sale | -325,263 | $44.65 | $14,522,993 | 2025-05-16 |
| MORRISSEY MICHAEL | Derivatives Exercise | 308,365 | 2025-05-16 | ||
| Haley Patrick J. | Derivatives Exercise | 116,383 | 2025-05-16 | ||
| Haley Patrick J. | Sale | -171,088 | $42.68 | $7,302,036 | 2025-05-16 |
| Peterson Amy C. | Derivatives Exercise | 40,000 | 2025-05-16 | ||
| Peterson Amy C. | Sale | -81,079 | $44.65 | $3,620,177 | 2025-05-16 |
| Senner Christopher J. | Derivatives Exercise | 100,000 | 2025-05-16 | ||
| Senner Christopher J. | Sale | -141,422 | $44.65 | $6,314,492 | 2025-05-16 |
| PAPADOPOULOS STELIOS | Sale | -36,508 | $44.35 | $1,619,130 | 2025-05-16 |
| PAPADOPOULOS STELIOS | Derivatives Exercise | 36,508 | 2025-05-16 | ||
| Aftab Dana | Sale | -30,693 | $44.65 | $1,370,442 | 2025-05-16 |
| POSTE GEORGE | Sale | -20,634 | $45.99 | $948,958 | 2025-05-16 |
| POSTE GEORGE | Derivatives Exercise | 20,634 | 2025-05-16 | ||
| Aftab Dana | Sale | -1,508 | $39 | $58,812 | 2025-05-05 |
| Senner Christopher J. | Grant, award...etc | 170,009 | 2025-03-31 | ||
| Haley Patrick J. | Grant, award...etc | 159,383 | 2025-03-31 | ||
| Aftab Dana | Grant, award...etc | 132,819 | 2025-03-31 | ||
| MORRISSEY MICHAEL | Grant, award...etc | 589,719 | 2025-03-31 | ||
| Hessekiel Jeffrey | Grant, award...etc | 154,070 | 2025-03-31 | ||
| Peterson Amy C. | Grant, award...etc | 159,383 | 2025-03-31 | ||
| Haley Patrick J. | Sale | -10,000 | $38.8 | $388,000 | 2025-03-05 |
| Hessekiel Jeffrey | Grant, award...etc | 52,192 | 2025-02-28 | ||
| Peterson Amy C. | Grant, award...etc | 52,192 | 2025-02-28 | ||
| Senner Christopher J. | Grant, award...etc | 59,648 | 2025-02-28 | ||
| WYSZOMIERSKI JACK L | Sale | -8,768 | $37.8 | $331,430 | 2025-02-28 |
| WYSZOMIERSKI JACK L | Derivatives Exercise | 15,874 | 2025-02-28 | ||
| MORRISSEY MICHAEL | Grant, award...etc | 184,909 | 2025-02-28 | ||
| Smith Julie | Sale | -73,808 | $38.13 | $2,814,299 | 2025-02-28 |
| Smith Julie | Derivatives Exercise | 73,808 | 2025-02-28 | ||
| Haley Patrick J. | Grant, award...etc | 47,718 | 2025-02-28 | ||
| Aftab Dana | Grant, award...etc | 49,209 | 2025-02-28 | ||
| Senner Christopher J. | Sale | -29,314 | $36.14 | $1,059,408 | 2025-02-26 |
| Senner Christopher J. | Derivatives Exercise | 29,314 | 2025-02-26 | ||
| Oliver Bob | Sale | -18,647 | $37.25 | $694,601 | 2025-02-26 |
| Oliver Bob | Derivatives Exercise | 15,147 | 2025-02-26 | ||
| Haley Patrick J. | Sale | -52,636 | $36.98 | $1,946,479 | 2025-02-26 |
| Aftab Dana | Sale | -26,987 | $36.75 | $991,772 | 2025-02-26 |
| Haley Patrick J. | Sale | -18,906 | $35 | $661,710 | 2025-02-19 |
| Hessekiel Jeffrey | Sale | -18,134 | $35 | $634,690 | 2025-02-19 |
| Aftab Dana | Sale | -28,748 | $35 | $1,006,180 | 2025-02-19 |
| Freire Maria C | Sale | -44,114 | $34.94 | $1,541,343 | 2025-02-19 |
| Freire Maria C | Derivatives Exercise | 44,114 | 2025-02-19 | ||
| MORRISSEY MICHAEL | Sale | -63,570 | $35 | $2,224,950 | 2025-02-19 |
| Eckhardt Sue Gail | Sale | -11,568 | $35.01 | $404,996 | 2025-02-19 |
| Eckhardt Sue Gail | Derivatives Exercise | 7,712 | 2025-02-19 | ||
| POSTE GEORGE | Sale | -15,874 | $34.74 | $551,463 | 2025-02-19 |
| POSTE GEORGE | Derivatives Exercise | 15,874 | 2025-02-19 | ||
| Beckerle Mary C | Sale | -12,210 | $34.87 | $425,763 | 2025-02-19 |
| Beckerle Mary C | Derivatives Exercise | 8,354 | 2025-02-19 | ||
| Senner Christopher J. | Sale | -21,591 | $35 | $755,685 | 2025-02-19 |
| Haley Patrick J. | Sale | -27,563 | $37.27 | $1,027,273 | 2025-01-17 |
| Haley Patrick J. | Grant, award...etc | 123,750 | 2025-01-17 | ||
| Senner Christopher J. | Sale | -35,949 | $37.27 | $1,339,819 | 2025-01-17 |
| Senner Christopher J. | Grant, award...etc | 132,973 | 2025-01-17 | ||
| Aftab Dana | Sale | -22,570 | $37.27 | $841,184 | 2025-01-17 |
| Aftab Dana | Grant, award...etc | 104,106 | 2025-01-17 | ||
| MORRISSEY MICHAEL | Sale | -120,244 | $37.27 | $4,481,494 | 2025-01-17 |
| MORRISSEY MICHAEL | Grant, award...etc | 473,226 | 2025-01-17 | ||
| Hessekiel Jeffrey | Sale | -26,289 | $37.27 | $979,791 | 2025-01-17 |
| Hessekiel Jeffrey | Grant, award...etc | 118,780 | 2025-01-17 | ||
| Hessekiel Jeffrey | Sale | -158,908 | $35.93 | $5,709,564 | 2024-12-02 |
| Hessekiel Jeffrey | Derivatives Exercise | 129,314 | 2024-12-02 | ||
| Haley Patrick J. | Sale | -10,000 | $35.27 | $352,700 | 2024-11-26 |
| Hessekiel Jeffrey | Sale | -14,672 | $35.05 | $514,254 | 2024-11-19 |
| Aftab Dana | Sale | -12,838 | $35.05 | $449,972 | 2024-11-19 |
| Peterson Amy C. | Sale | -27,224 | $35.05 | $954,201 | 2024-11-19 |
| Senner Christopher J. | Sale | -17,506 | $35.05 | $613,585 | 2024-11-19 |
| MORRISSEY MICHAEL | Sale | -47,642 | $35.05 | $1,669,852 | 2024-11-19 |
| Haley Patrick J. | Sale | -56,260 | $35.05 | $1,971,913 | 2024-11-19 |
| Aftab Dana | Sale | -96,986 | $35 | $3,394,510 | 2024-11-07 |
| Aftab Dana | Derivatives Exercise | 96,986 | 2024-11-07 |
The information provided in this report about EXEL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Exelixis, Inc(NASDAQ:EXEL) 
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...
Website: http://www.exelixis.com
Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology